BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Youinou P, Renaudineau Y. The paradox of CD5-expressing B cells in systemic lupus erythematosus. Autoimmun Rev. 2007;7:149-154. [PMID: 18035326 DOI: 10.1016/j.autrev.2007.02.016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Polese L, Boetto R, De Franchis G, Angriman I, Porzionato A, Norberto L, Sturniolo GC, Macchi V, De Caro R, Merigliano S. B1a lymphocytes in the rectal mucosa of ulcerative colitis patients. World J Gastroenterol 2012; 18(2): 144-149 [PMID: 22253520 DOI: 10.3748/wjg.v18.i2.144] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
2 Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Revisiting Libman–Sacks Endocarditis: A Historical Review and Update. Clinic Rev Allerg Immunol 2009;36:126-30. [DOI: 10.1007/s12016-008-8113-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
3 Zhang J, Jia G, Liu Q, Hu J, Yan M, Yang B, Yang H, Zhou W, Li J. Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis. Immunology 2015;144:56-67. [PMID: 24962817 DOI: 10.1111/imm.12347] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
4 Bunch DO, McGregor JG, Khandoobhai NB, Aybar LT, Burkart ME, Hu Y, Hogan SL, Poulton CJ, Berg EA, Falk RJ, Nachman PH. Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab. Clin J Am Soc Nephrol 2013;8:382-91. [PMID: 23293123 DOI: 10.2215/CJN.03950412] [Cited by in Crossref: 64] [Cited by in F6Publishing: 35] [Article Influence: 7.1] [Reference Citation Analysis]
5 Mishima Y, Ishihara S, Amano Y, Oshima N, Kadota C, Otani A, Moriyama I, Li YY, Aziz MM, Kinoshita Y. Alterations of peripheral blood CD5+ B cells in inflammatory bowel disease. Scand J Gastroenterol. 2009;44:172-179. [PMID: 18830898 DOI: 10.1080/00365520802433223] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
6 Tumurkhuu G, Koide N, Dagvadorj J, Noman AS, Khuda II, Naiki Y, Komatsu T, Yoshida T, Yokochi T. B1 cells produce nitric oxide in response to a series of toll-like receptor ligands. Cell Immunol 2010;261:122-7. [PMID: 20036355 DOI: 10.1016/j.cellimm.2009.11.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
7 Garaud JC, Schickel JN, Blaison G, Knapp AM, Dembele D, Ruer-Laventie J, Korganow AS, Martin T, Soulas-Sprauel P, Pasquali JL. B cell signature during inactive systemic lupus is heterogeneous: toward a biological dissection of lupus. PLoS One 2011;6:e23900. [PMID: 21886837 DOI: 10.1371/journal.pone.0023900] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
8 Scambi C, La Verde V, De Franceschi L, Barausse G, Poli F, Benedetti F, Sorio M, Deriu F, Roncada P, Bortolami O, Turrini F, Caramaschi P, Stranieri C, Bambara LM, Biasi D. Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H. PLoS One 2010;5:e12162. [PMID: 20730046 DOI: 10.1371/journal.pone.0012162] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
9 Geginat J, Vasco M, Gerosa M, Tas SW, Pagani M, Grassi F, Flavell RA, Meroni P, Abrignani S. IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus. Semin Immunol 2019;44:101330. [PMID: 31735515 DOI: 10.1016/j.smim.2019.101330] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
10 Zhong X, Lau S, Bai C, Degauque N, Holodick NE, Steven SJ, Tumang J, Gao W, Rothstein TL. A novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice. Arthritis Rheum 2009;60:3734-43. [PMID: 19950285 DOI: 10.1002/art.25015] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
11 Roudafshani Z, Jazayeri MH, Mahmoudi AR, Nedaeinia R, Safari E, Jazayeri A. Evaluation of the frequency of CD5+ B cells as natural immunoglobulin M producers and circulating soluble CD5 in patients with bladder cancer. Mol Biol Rep 2019;46:6405-11. [PMID: 31587183 DOI: 10.1007/s11033-019-05087-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Morris G, Puri BK, Olive L, Carvalho AF, Berk M, Maes M. Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: Association with inflammation, oxidative and nitrosative stress and autoimmune responses. Pharmacological Research 2019;148:104408. [DOI: 10.1016/j.phrs.2019.104408] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
13 Taher TE, Bystrom J, Ong VH, Isenberg DA, Renaudineau Y, Abraham DJ, Mageed RA. Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity. Clin Rev Allergy Immunol 2017;53:237-64. [PMID: 28456914 DOI: 10.1007/s12016-017-8609-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
14 Hagn M, Blackwell SE, Beyer T, Ebel V, Fabricius D, Lindner S, Stilgenbauer S, Simmet T, Tam C, Neeson P, Trapani JA, Schrezenmeier H, Weiner GJ, Jahrsdörfer B. B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21. Int Immunol 2014;26:383-95. [PMID: 24497611 DOI: 10.1093/intimm/dxu001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
15 Malkova A, Starshinova A, Zinchenko Y, Gavrilova N, Kudryavtsev I, Lapin S, Mazing A, Surkova E, Pavlova M, Belaeva E, Stepanenko Т, Yablonskiy P, Shoenfeld Y. New laboratory criteria of the autoimmune inflammation in pulmonary sarcoidosis and tuberculosis. Clin Immunol 2021;227:108724. [PMID: 33845192 DOI: 10.1016/j.clim.2021.108724] [Reference Citation Analysis]
16 Sonoki T, Ishihara S, Uneda S, Hanaoka N, Kurimoto M, Matsuoka H, Nakakuma H. Aggressive CD5-positive B-cell lymphoma after remission of CD5-negative follicular lymphoma with distinct immunoglobulin heavy chain rearrangement and translocation. Int J Hematol 2008;88:299-303. [PMID: 18758895 DOI: 10.1007/s12185-008-0160-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
17 Régent A, Bussone G, Kaveri SV, Mouthon L. [Humoral and cellular autoimmunity: from physiology to pathology]. Rev Med Interne 2009;30:H1-8. [PMID: 19995650 DOI: 10.1016/S0248-8663(09)73166-2] [Reference Citation Analysis]
18 Hagn M, Ebel V, Sontheimer K, Schwesinger E, Lunov O, Beyer T, Fabricius D, Barth TF, Viardot A, Stilgenbauer S. CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B. Eur J Immunol. 2010;40:2060-2069. [PMID: 20394077 DOI: 10.1002/eji.200940113] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
19 Garaud S, Youinou P, Renaudineau Y. DNA methylation and B-cell autoreactivity. Adv Exp Med Biol 2011;711:50-60. [PMID: 21627042 DOI: 10.1007/978-1-4419-8216-2_5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
20 Berrih-aknin S, Ragheb S, Le Panse R, Lisak RP. Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis. Autoimmunity Reviews 2013;12:885-93. [DOI: 10.1016/j.autrev.2013.03.011] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
21 Garaud S, Le Dantec C, de Mendoza AR, Mageed RA, Youinou P, Renaudineau Y. IL-10 production by B cells expressing CD5 with the alternative exon 1B. Ann N Y Acad Sci 2009;1173:280-5. [PMID: 19758163 DOI: 10.1111/j.1749-6632.2009.04616.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
22 Boldizsar F, Tarjanyi O, Nemeth P, Mikecz K, Glant TT. Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice. Int Immunol 2009;21:511-22. [PMID: 19254958 DOI: 10.1093/intimm/dxp018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
23 Alonso R, Buors C, Le Dantec C, Hillion S, Pers JO, Saraux A, Montero E, Marianowski R, Loisel S, Devauchelle V, Youinou P, Renaudineau Y. Aberrant expression of CD6 on B-cell subsets from patients with Sjögren's syndrome. J Autoimmun 2010;35:336-41. [PMID: 20810246 DOI: 10.1016/j.jaut.2010.07.005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
24 Knippenberg S, Smolders J, Thewissen M, Peelen E, Tervaert JW, Hupperts R, Damoiseaux J. Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis. Mult Scler 2011;17:1418-23. [PMID: 21690147 DOI: 10.1177/1352458511412655] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
25 Meyer-Bahlburg A, Rawlings DJ. Differential impact of Toll-like receptor signaling on distinct B cell subpopulations. Front Biosci (Landmark Ed) 2012;17:1499-516. [PMID: 22201817 DOI: 10.2741/4000] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
26 Lee HT, Shiao YM, Wu TH, Chen WS, Hsu YH, Tsai SF, Tsai CY. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. J Rheumatol. 2010;37:45-52. [PMID: 19955043 DOI: 10.3899/jrheum.090450] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
27 Karampetsou MP, Andonopoulos AP, Liossis SC. Treatment with TNFα blockers induces phenotypical and functional aberrations in peripheral B cells. Clinical Immunology 2011;140:8-17. [DOI: 10.1016/j.clim.2011.01.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
28 Omar HH, Nasef SI, Omar HH, Ghaly MS. CD5+ B lymphocytes in systemic lupus erythematosus patients: relation to disease activity. Clin Rheumatol 2017;36:2719-26. [PMID: 28918596 DOI: 10.1007/s10067-017-3818-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
29 Ahmetspahic D, Schwarte K, Ambrée O, Bürger C, Falcone V, Seiler K, Kooybaran MR, Grosse L, Roos F, Scheffer J, Jörgens S, Koelkebeck K, Dannlowski U, Arolt V, Scheu S, Alferink J. Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders. J Neuroimmune Pharmacol 2018;13:90-9. [PMID: 28905187 DOI: 10.1007/s11481-017-9763-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
30 Sauerborn M, Schellekens H. B-1 cells and naturally occurring antibodies: influencing the immunogenicity of recombinant human therapeutic proteins? Curr Opin Biotechnol. 2009;20:715-721. [PMID: 19892544 DOI: 10.1016/j.copbio.2009.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
31 Hodgson K, Ferrer G, Montserrat E, Moreno C. Chronic lymphocytic leukemia and autoimmunity: a systematic review. Haematologica 2011;96:752-61. [PMID: 21242190 DOI: 10.3324/haematol.2010.036152] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 7.1] [Reference Citation Analysis]
32 Kijimoto-Ochiai S, Kamimura K, Koda T. Neu-medullocytes, sialidase-positive B cells in the thymus, express autoimmune regulator (AIRE). Sci Rep 2019;9:858. [PMID: 30696872 DOI: 10.1038/s41598-018-37225-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Pfau JC, Hurley K, Peterson C, Coker L, Fowers C, Marcum R. Activation and trafficking of peritoneal B1a B-cells in response to amphibole asbestos. J Immunotoxicol 2014;11:90-8. [PMID: 23746315 DOI: 10.3109/1547691X.2013.796024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
34 Fuda FS, Karandikar NJ, Chen W. Significant CD5 expression on normal stage 3 hematogones and mature B Lymphocytes in bone marrow. Am J Clin Pathol 2009;132:733-7. [PMID: 19846815 DOI: 10.1309/AJCPU5E3NXEKLFIY] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]